6/9/2023: This presentation given by BrainFutures’ David Esselman and Fluence’s Victor Cabral at the 2023 Mental Health America Conference covers the core elements of psychedelic-assisted therapy and how this treatment can map into existing systems that clinicians and payers are already using to facilitate reimbursement.
3/9/2023: This panel by and for primary care providers discusses how clinicians can understand their role in helping patients safely access psychedelic-assisted therapy.
10/14/2022: This presentation hosted by BrainFutures’ David Esselman and Dr. Heidi Allen from Columbia University provides a survey of current research in the field and the future innovation and research needed to expand access, reduce costs, and bolster patient safety for this treatment.
9/18/2022: David Esselman discusses BrainFutures’ current work in the psychedelic-assisted therapy field alongside Jacqueline Lampert, Principal from the Rockingstone Group.
® 2024 BrainFutures All Rights Reserved.
